HALO logo
halo search icon
AYTU
Aytu BioPharma, Inc.

AYTU · Aytu BioPharma, Inc.

2.07

USD
-0.02 (-0.957%)
02/10/2026 04:00:00 PM
Price change (7D)

Unlock stock Insights

Create a free account to unlock price targets, recommendations, and commentary.

Overview

Market Cap

US$22.49M

PE

0.00

EV/EBITDA

N/A

DIV Yield

0%

Payout Ratio

0%

MQV Rating

5Very Weak

As at 02/10/2026 04:00:00 PM

Price Chart

Description

Aytu Biopharma, Inc. is a specialty pharmaceutical company, which engages in identifying, acquiring, and commercializing novel products. It operates through the Rx and Consumer Health segments. The RX segment consists of various prescription pharmaceutical products sold through third parties. The Consumer Health segment includes various consumer health products sold directly to consumers. Its products include Adzenys ER, Adzenys XR-ODT, Cotempla XR-ODT, Karbinal ER, Poly-Vi-Flor, Tri-Vi-Flor, Generic Tussionex, Tuzistra XR, and ZolpiMist. The company was founded on August 9, 2002 and is headquartered in Denver, CO.

  • All-Companies
  • All-Consensus
  • HALO All
  • HALO Consensus Value
  • Hammer Bullish
  • Recent Earnings downgrade
  • Recent Price downgrade

Key Fundamentals

EPS 3 yr Growth

-77.30%

EBITDA Margin

-7.60%

Operating Cashflow

$3m

Free Cash Flow Return

8.60%

ROIC

-37.50%

Interest Coverage

-2.30

Quick Ratio

1.00

Performance

52 weeks range

Low 1.8 - 3.07

Trade Value (12mth)

US$40,663.00

1 week

7.55%

1 month

1.79%

YTD

-17.69%

1 year

31.03%

All time high

11803900.00

Additional Data

Shares Outstanding (Fully Diluted)

19m

HALO Sector

Healthcare

Next Company Report Date

28-Sep-27

Next Ex Dividend Date

N/A

Next Dividend Pay Date

N/A

Reporting Currency

USD

Short Sell (% of issue)

0.00

Consensus

Lock Icon

Unlock full consensus

Consensus score

Lock Icon/10

Recommendation

Buy

Target price

Lock Icon

Deviation

Lock Icon

Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Neutral

Halo Model

Mqv

Very Weak

Garp

Very Weak

Mqv Small

Neutral

Momentum

Price

Strong

Earnings

Very Weak

Growth

Earnings

Weak

Dividends

Very Weak

Quality

Capital Efficiency

Very Weak

Balance Sheet

Very Weak

Valuation

Lock Icon

Unlock full dataset

Value

Lock Icon

Consensus

Lock Icon

Yield

Lock Icon

News & Announcements

DateEvent
23 September 26EDG
23 September 26EDG
23 September 26EDG
23 September 26EDG
26 June 26EDG

Key Stakeholders

NameTitle
Laurence W. LyttonIndividual
Joshua R. DisbrowIndividual
Jarrett T. DisbrowIndividual
Ryan J. SelhornIndividual
Greg PyszczymukaIndividual

See beyond the curve.

One solution for research, investing and model portfolio management.
Start FREE Trial
Want to learn more?Frequently asked questions.
1
What is the current share price of Aytu BioPharma, Inc. (AYTU:NAS)?
Halo FAQ
The current share price of Aytu BioPharma, Inc. (AYTU:NAS) is USD$2.07.
2
What is the 52-week high share price for Aytu BioPharma, Inc. (AYTU:NAS)?
Halo FAQ
The 52-week high share price for Aytu BioPharma, Inc. (AYTU:NAS) is USD$3.07.
3
What is the 52-week low share price for Aytu BioPharma, Inc. (AYTU:NAS)?
Halo FAQ
The 52-week low share price for Aytu BioPharma, Inc. (AYTU:NAS) is USD$1.80.
4
What is the dividend yield for Aytu BioPharma, Inc. (AYTU:NAS)?
Halo FAQ
Aytu BioPharma, Inc. (AYTU:NAS) does not pay a dividend.
5
What was Aytu BioPharma, Inc. (AYTU:NAS) last dividend payment?
Halo FAQ
Aytu BioPharma, Inc. (AYTU:NAS) does not pay a dividend.
6
What is the franking level for Aytu BioPharma, Inc. (AYTU:NAS)?
Halo FAQ
Aytu BioPharma, Inc. (AYTU:NAS) has a franking level of 0.00%.
7
In which sector is Aytu BioPharma, Inc. (AYTU:NAS) classified?
Halo FAQ
Aytu BioPharma, Inc. (AYTU:NAS) is classified in the Healthcare.